Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
ACS Infectious Diseases|November 1, 2016
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseStephen Nakazawa Hewitt, David M Dranow, Benjamin G Horst, et al.Journal of Medicinal Chemistry|September 30, 2010
Cdc7 kinase inhibitors: 5-heteroaryl-3-carboxamido-2-aryl pyrroles as potential antitumor agents. 1. Lead findingMaria Menichincheri, Clara Albanese, Cristina Alli, et al.Science Translational Medicine|October 23, 2024
Cryptosporidium lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.Research Square|December 9, 2024
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.NPJ Drug Discovery|March 11, 2025
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data miningKarla P Godinez-Macias, Daisy Chen, J Lincoln Wallis, et al.Journal of Medicinal Chemistry|June 2, 2026
Structure-Guided Optimization of Novel Inhibitors of Plasmodium Lysyl-tRNA Synthetase with Multistage Activity against Malaria ParasitesBarbara Forte, Fiona Bellany, Peter S Campbell, et al.Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.Pageof 3